Klotho protein: a new insight into the pathogenesis of essential hypertension

Richa Awasthi1, Priyanka Thapa Manger2, Rajesh Kumar Khare3

  • 1Department of Biochemistry, Integral Institute of Medical Sciences and Research, Integral University, Lucknow, India.

Clinical Hypertension
|November 30, 2024
PubMed

Insights

Lower klotho protein levels are significantly associated with essential hypertension. This suggests klotho may serve as a predictive marker for hypertension risk.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Cardiovascular Research

Background:

  • Essential hypertension is a widespread health issue with unclear underlying mechanisms.
  • Klotho protein, both membrane-bound and soluble, influences hypertension via vascular function and sodium balance.

Purpose of the Study:

  • To investigate the association between klotho protein levels and essential hypertension.

Main Methods:

  • A case-control study involving 164 hypertensive patients and 164 normotensive controls.
  • Klotho protein levels were quantified using sandwich enzyme-linked immunosorbent assay (ELISA) from blood samples.
  • Data analysis included structural equation modeling and receiver operating characteristic (ROC) curve analysis.

Main Results:

  • Hypertensive cases exhibited significantly lower klotho protein levels compared to controls (1.52 ± 0.87 vs. 2.45 ± 0.90, P < 0.001).
  • Klotho protein showed a negative association with blood pressure.
  • The ROC curve analysis indicated a significant diagnostic value for klotho and blood pressure (AUC = 0.765, P < 0.001).

Conclusions:

  • Reduced klotho levels are linked to essential hypertension, suggesting its potential as a prognostic and predictive biomarker.
  • Klotho may play a role in the pathogenesis of essential hypertension.
  • Further understanding of klotho's function could pave the way for novel therapeutic strategies.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
455
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.5K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
479